Apoptosis
Apoptosis(凋亡)
FKBP (FK506-binding protein) is one of two major immunophilins and most of FKBP family members bind FK506 and show peptidylprolyl cis/trans isomerase (PPIase) activity. Small size FKBP family members contain only FK506-binding domain, while FKBPs with large molecular weights possess extra domains such as tetratricopeptide repeat domains, calmodulin binding and transmembrane motifs. FKBPs are involved in several biochemical processes including protein folding, receptor signaling, protein trafficking and transcription. FKBP family proteins play important functional roles in the T-cell activation, when complexed with their ligands.
FK506-binding proteins 1a and 1b (FKBP1a/1b) are immunophilin proteins that bind the immunosuppressant agent FK506 and AY 22989. FKBP12 is a ubiquitous abundant protein that acts as a receptor for FK506, binds tightly to intracellular calcium release channels and to the transforming growth factor β (TGF-β) type I receptor.
Apoptosis 相关产品(777)
- GC73996PROTAC AR/AR-V7 degrader-1CAS: 2841308-96-9纯度: >98.00%
PROTAC AR/AR-V7 degrader-1(27c)是一种基于PROTAC的双AR AR-V7降解器,AR和AR-V7的DC50值分别为2.67和2.64μM。
- GC74029ASCT2-IN-1CAS: 3032651-18-3纯度: >98.00%
ASCT2-IN-1(化合物20k)是一种ASCT2抑制剂,在A549和HEK293细胞中的IC50值分别为5.6 μM和3.5 μM。
- GC74050PROTAC CDK4/6 degrader 1CAS: 3025082-14-5纯度: >98.00%
PROTAC CDK4/6 degrader 1(化合物7f)是CDK4和CDK6的双重降解剂,DC50分别为10.5和2.5 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC73982 | NSD-IN-3 | 744260-15-9 | >98.00% | |
NSD-IN-3(化合物3)是一种强效的核受体结合SET结构域(NSD)抑制剂。 | ||||
| GC73990 | SDU-071 | - | >98.00% | |
SDU-071是BRD4-p53抑制剂的强效口服活性抑制剂。 | ||||
| GC73995 | XL44 | 2637949-91-6 | >98.00% | |
XL44是一种hRpn13结合物,可诱导hRpn13依赖性细胞凋亡,并通过pclaf依赖性机制限制细胞活力。 | ||||
| GC73996 | PROTAC AR/AR-V7 degrader-1 | 2841308-96-9 | >98.00% | |
PROTAC AR/AR-V7 degrader-1(27c)是一种基于PROTAC的双AR AR-V7降解器,AR和AR-V7的DC50值分别为2.67和2.64μM。 | ||||
| GC74001 | TS-24 | 1563260-97-8 | >98.00% | |
TS-24是组织蛋白酶S的抑制剂,IC50为4.3μM。 | ||||
| GC74007 | SelSA | 1225038-92-5 | >99.00% | |
SelSA是一种选择性的口服活性组蛋白去乙酰化酶6 (HDAC6)抑制剂,IC50为56.9 nM。 | ||||
| GC74024 | BPU | - | >99.00% | |
BPU在亚g1期阻止细胞周期进程。 | ||||
| GC74029 | ASCT2-IN-1 | 3032651-18-3 | >98.00% | |
ASCT2-IN-1(化合物20k)是一种ASCT2抑制剂,在A549和HEK293细胞中的IC50值分别为5.6 μM和3.5 μM。 | ||||
| GC74030 | ASCT2-IN-2 | - | >99.00% | |
ASCT2-IN-2(化合物25e)是一种ASCT2抑制剂,IC50为5.14μM。 | ||||
| GC74042 | SpiD3 | 3033533-25-1 | >98.00% | |
SpiD3是一种新型的螺环二聚体。 | ||||
| GC74047 | UR778Br | 866127-80-2 | >99.00% | |
UR778Br靶向IQGAP1蛋白的GTP酶激活蛋白相关结构域(GRD结构域)。 | ||||
| GC74050 | PROTAC CDK4/6 degrader 1 | 3025082-14-5 | >98.00% | |
PROTAC CDK4/6 degrader 1(化合物7f)是CDK4和CDK6的双重降解剂,DC50分别为10.5和2.5 nM。 | ||||
| GC74075 | SC428 | 1898232-70-6 | >98.00% | |
SC428是一种靶向N-末端结构域的雄激素受体(AR)抑制剂。 | ||||
| GC74102 | Apomine | 126411-13-0 | >99.00% | |
Apomine (SR-45023A)是一种抑制胆固醇合成中甲羟戊酸/类异戊二烯途径的抗肿瘤药物。 | ||||
| GC74159 | MK-0731 | 845256-65-7 | >99.00% | |
MK-0731是一种选择性、非竞争性和变构驱动蛋白纺锤体蛋白(KSP)抑制剂,IC50为2.2 nM,pKa为7.6。 | ||||
| GC74187 | Salicylic acid-13C6 | 1189678-81-6 | >97.00% | |
Salicylic acid-13C6是13c标记的水杨酸。 | ||||
| GC74252 | Euphornin | 80454-47-3 | >98.00% | |
Euphornin是一种抗癌剂,可从E. helioscopia中分离得到。 | ||||
| GC74256 | Condurango glycoside A | 11051-90-4 | >95.00% | |
Condurango glycoside A是p53的激活剂。 | ||||
| GC74267 | Propylparaben-d4 | 1219802-67-1 | >99.00% | |
Propylparaben-d4是氘标记的尼泊金丙酯。 | ||||
| GC74270 | Penduletin | 569-80-2 | >99.00% | |
Penduletin是一种黄酮类化合物,可以从白蜡和牡荆中分离出来。 | ||||
| GC74313 | MYBMIM | - | >99.00% | |
MYBMIM是MYB:CBP/P300复合物分子组装的抑制剂。 | ||||
| GC74476 | Seribantumab | 1334296-12-6 | >95.00% | |
Seribantumab (MM 121)是一种靶向HER3的全人源IgG2单克隆抗体。 | ||||
| GC74477 | Tigatuzumab | 918127-53-4 | >95.00% | |
Tigatuzumab(CS-1008)是一种靶向死亡受体5(DR5)的人源化IgG1单克隆抗体。 | ||||
| GC74482 | Drozitumab | 912628-39-8 | >99.00% | |
Drozitumab(PRO 95780)是一种结合死亡受体DR5的人激动性单克隆抗体。 | ||||
